Please provide your email address to receive an email when new articles are posted on . “Many transgender boys do not want to compromise their adult height,” Sabine E. Hannema, MD, PhD, a pediatric ...
England's National Health Service banned the use of puberty blockers for children seeking treatment for gender dysphoria, citing limited research. Puberty blockers, or gonadotropin-releasing hormone ...
NHS England has made the landmark decision that puberty suppressing hormones (PSH) will not be available as a routine commissioning treatment option for children and young people who have gender ...
Combining ovarian function suppression (GNRH analog) and chemotherapy with epirubicin (E) cisplatin (C) and fluorouracil as continuous infusion (FUci) (ECF regimen) as primary treatment for ...
Please provide your email address to receive an email when new articles are posted on . Gonadotropin-releasing hormone analogue therapy is linked to improvement in final adult height and reduced BMI ...
In 1977, the Nobel Prize in Physiology or Medicine was awarded to Roger Guillemin and Andrew Schally for their discovery and synthesis of gonadotropin-releasing hormone (GnRH), a key regulator of ...
Central precocious puberty (CPP) is characterised by the premature activation of the hypothalamic-pituitary-gonadal (HPG) axis, resulting in early development of secondary sexual characteristics. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results